Caam
2 known investors
Find your way into Caam
CaaMTech is a pharmaceutical drug discovery company that engineers novel small-molecule psychedelic-inspired therapeutics for mental health treatment through structure-activity optimization and safety screening. The company conducts fundamental research on tryptamine compounds, develops intellectual property, and aims to support the psychedelics industry with scientific foundations and validated drug candidates.
Founders & leadership
Investors · 2
Frequently asked questions
- What does Caam do?
- CaaMTech is a pharmaceutical drug discovery company that engineers novel small-molecule psychedelic-inspired therapeutics for mental health treatment through structure-activity optimization and safety screening. The company conducts fundamental research on tryptamine compounds, develops intellectual property, and aims to support the psychedelics industry with scientific foundations and validated drug candidates.
- Who founded Caam?
- Caam was founded by Andrew Chadeayne.
- Who are Caam's investors?
- Caam's investors include Kortschak Investments L.P., Noetic.